Walgreens Boots Alliance (WBA)
(Delayed Data from NSDQ)
$8.91 USD
-0.17 (-1.87%)
Updated Oct 9, 2024 04:00 PM ET
After-Market: $8.91 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.91 USD
-0.17 (-1.87%)
Updated Oct 9, 2024 04:00 PM ET
After-Market: $8.91 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth F Momentum D VGM
Zacks News
Can Walgreens (WBA) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Walgreens (WBA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
How to Boost Your Portfolio with Top Retail and Wholesale Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $49.94, moving -0.36% from the previous trading session.
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $50.57, moving -1.02% from the previous trading session.
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $51.29, marking a -0.95% move from the previous day.
Stock Market News for Sep 3, 2021
by Zacks Equity Research
Benchmarks closed in the green on Thursday as investors rejoiced improvement in weekly jobless claims ahead of August's jobs data scheduled for release on Friday.
Stock Market News for Sep 1, 2021
by Zacks Equity Research
Benchmarks closed in the red on Tuesday as investors await jobs data for August scheduled for release on Sep 3 to trace when the Federal Reserve may begin tapering its bond purchases.
Walgreens (WBA) to Stock LUCEMYRA Across US With New Pact
by Zacks Equity Research
Walgreens' (WBA) agreement with US WorldMeds finalized as recent report outlines a surge of 30% in drug overdose deaths in 2020.
Walgreens Boots Alliance (WBA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $48.48 in the latest trading session, marking a +1.34% move from the prior day.
Walgreens (WBA) Provides Flu Shots Nationwide for Ages 3 & More
by Zacks Equity Research
Walgreens (WBA) is ready to co-administer COVID-19 vaccines and flu shots anticipating COVID-19 boosters in September.
Stock Market News for Aug 12, 2021
by Zacks Equity Research
U.S. stock markets closed mostly higher on Wednesday after Senate Democrats passed a budget resolution for the $3.5 trillion bill.
Stock Market News for Aug 5, 2021
by Zacks Equity Research
The Dow and the S&P 500 closed in the red on Wednesday weighed by a lower-than-expected private-sector jobs report and Fed's Vice Chairman Richard Clarida's comment on higher interest rates in 2023 given the current path of economic recovery.
The Zacks Analyst Blog Highlights: Johnson & Johnson, Oracle, SAP, Cigna and Walgreens Boots Alliance
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Johnson & Johnson, Oracle, SAP, Cigna and Walgreens Boots Alliance
Top Research Reports for Johnson & Johnson, Oracle & SAP
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Oracle (ORCL), and SAP SE (SAP).
McKesson (MCK) Enters Deal to Divest Some European Businesses
by Zacks Equity Research
McKesson (MCK) to sell off some of its European ventures to streamline its business and prioritize investments in areas where it has better expertise.
Walgreens (WBA), VillageMD State 2021 Primary Healthcare Goal
by Zacks Equity Research
With this Walgreens (WBA) and VillageMD are on track to achieve their January 2021 goal of opening at least 600 Village Medical primary care practices in more than 30 U.S. markets over the next four years.
Zacks Industry Outlook Highlights: CVS Health, Walgreen Boots, Herbalife and Amazon
by Zacks Equity Research
Zacks Industry Outlook Highlights: CVS Health, Walgreen Boots, Herbalife and Amazon
Bear of the Day: Rite Aid (RAD)
by David Bartosiak
The competition is fierce and earnings are moving in the wrong direction
3 Retail Pharmacy and Drugstore Stocks to Watch Amid Pandemic Woes
by Urmimala Biswas
The Zacks Retail Pharmacy and Drugstore industry is gaining from growing demand for digital healthcare support. Industry players CVS, WBA and HLF are set to gain the most. However, Amazon's entry threat disrupts this uptrend.
Company News for Jul 2, 2021
by Zacks Equity Research
Companies in The News Are: WBA, UAL, MKSI, ATC, SMPL.
Walgreens Boots (WBA) Q3 Earnings Top Estimates, 2021 View Up
by Zacks Equity Research
Walgreens Boots (WBA) revenues improve 12.1% year-over-year in the third quarter on robust growth in the International and United States segments.
Abbott (ABT) CE-Marked Panbio Test Now Widely Offered in Europe
by Zacks Equity Research
Abbott's (ABT) Panbio COVID-19 Antigen Self-Test is expected to facilitate mass screenings and aid in resumption of daily life activities with the gradual reopening of economies worldwide.
Why Walgreens Boots Alliance (WBA) Might Surprise This Earnings Season
by Zacks Equity Research
Walgreens Boots Alliance (WBA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Walgreens (WBA) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Faster adoption of digital health and improved business environment are expected to have contributed to Walgreens' (WBA) third-quarter performance.
Walgreens Boots Alliance (WBA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Walgreens (WBA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.